ii4sm – Semantic interoperability to connect healthcare domains

ii4sm is addressing critical challenges at the intersection between healthcare and the pharmaceutical industry providing support for data integration, provisioning standardization and contextual analysis. 

Several challenges put substantial stress on drug safety from various pressure points, including:

• Increased public political, ethical and economical attention to pharmacovigilance (PV)

• Increased demand for integrated use of internal and external data (FDA – Sentinel, EMEA Volume 9, etc.)

• Increased post-market commitments and outcome orientation (adding to development cost and PV workload)

• Increased adverse event reporting volume 

• Increasing pressure on pharma resources due to reduced R&D productivity and reimbursement pressures

Moving forward, personalized medicine - combining genotypic with phenotypic data to design the most suitable therapies – will require healthcare stakeholders to access an integrated, broad spectrum information model.

One study*, focusing on the lost efficiency in the communication of healthcare information, estimated that US$77.8 billion per year could be saved by implementing an effective interoperability standard. Semantic interoperability is the glue needed by the healthcare stakeholders to connect isolated information sources and extract valuable insights to drive more cost-efficient and productive safety and healthcare operations today.

ii4sm invested substantially and generated IP in the field of computable semantic interoperability to grow the business of information management to reach levels of information sharing never possible before.

Read more on the benefits deriving from cutting edge Healthcare Applications based on Computable Semantic Interoperability

* Jan Walker, Eric Pan, Douglas Johnston, Julia Adler-Milstein, David W. Bates and Blackford Middleton, The Value of Healthcare Information Exchange and Interoperability Health Affairs, 19 January 2005